JP2007505894A5 - - Google Patents

Download PDF

Info

Publication number
JP2007505894A5
JP2007505894A5 JP2006526810A JP2006526810A JP2007505894A5 JP 2007505894 A5 JP2007505894 A5 JP 2007505894A5 JP 2006526810 A JP2006526810 A JP 2006526810A JP 2006526810 A JP2006526810 A JP 2006526810A JP 2007505894 A5 JP2007505894 A5 JP 2007505894A5
Authority
JP
Japan
Prior art keywords
active ingredient
delivery system
drug delivery
oral drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006526810A
Other languages
English (en)
Japanese (ja)
Other versions
JP5666075B2 (ja
JP2007505894A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2004/000192 external-priority patent/WO2005039481A2/en
Publication of JP2007505894A publication Critical patent/JP2007505894A/ja
Publication of JP2007505894A5 publication Critical patent/JP2007505894A5/ja
Application granted granted Critical
Publication of JP5666075B2 publication Critical patent/JP5666075B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

JP2006526810A 2003-09-19 2004-06-30 経口薬送達システム Expired - Lifetime JP5666075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN987/MUM/2003 2003-09-19
IN987MU2003 2003-09-19
PCT/IN2004/000192 WO2005039481A2 (en) 2003-09-19 2004-06-30 Oral drug delivery system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014210770A Division JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Publications (3)

Publication Number Publication Date
JP2007505894A JP2007505894A (ja) 2007-03-15
JP2007505894A5 true JP2007505894A5 (enExample) 2012-06-14
JP5666075B2 JP5666075B2 (ja) 2015-02-12

Family

ID=34509346

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006526810A Expired - Lifetime JP5666075B2 (ja) 2003-09-19 2004-06-30 経口薬送達システム
JP2014210770A Pending JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014210770A Pending JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Country Status (17)

Country Link
US (2) US8163306B2 (enExample)
EP (1) EP1663175B1 (enExample)
JP (2) JP5666075B2 (enExample)
KR (1) KR101164881B1 (enExample)
CN (1) CN1856299B (enExample)
AP (1) AP2006003602A0 (enExample)
AT (1) ATE551051T1 (enExample)
AU (2) AU2004283565C1 (enExample)
BR (1) BRPI0414305A (enExample)
CA (1) CA2543353C (enExample)
EA (1) EA013106B1 (enExample)
IL (1) IL174396A (enExample)
NZ (1) NZ546543A (enExample)
PL (2) PL381756A1 (enExample)
UA (1) UA85850C2 (enExample)
WO (1) WO2005039481A2 (enExample)
ZA (1) ZA200602276B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03008997A (es) * 2001-04-10 2004-02-12 Sun Pharmaceutical Ind Ltd Composicion de liberacion por impulso temporizado.
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
AP2006003602A0 (en) * 2003-09-19 2006-04-30 Sun Pharmaceutical Ind Ltd Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8431156B2 (en) * 2005-02-22 2013-04-30 Sun Pharma Advanced Research Company Ltd. Pharmaceutical composition
CN101146521A (zh) * 2005-03-14 2008-03-19 太阳医药高级研究有限公司 提供包含纤维素和甲基丙烯酸衍生物包衣的口服药物输送系统
US8920837B2 (en) 2005-07-01 2014-12-30 Rubicon Research Private Limited Sustained release dosage form
EP1945189A4 (en) * 2005-11-03 2012-08-15 Sun Pharmaceutical Ind Ltd CONTROLLED RELEASE COATED TABLETS CHARACTERIZED BY PROLONGED GASTRIC RETENTION
WO2009087663A2 (en) * 2007-11-30 2009-07-16 Sun Pharmaceutical Industries Ltd. Oral controlled release coated tablet
CA2715584A1 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd. Oral controlled release tablet
KR20140069381A (ko) * 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 서방출 투여형
US10485770B2 (en) * 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
FR2985177B1 (fr) * 2012-01-02 2016-04-01 Oreal Composition cosmetique solide aqueuse comprenant de l'alkylcellulose, au moins deux huiles non volatiles et au moins deux agents tensioactifs
FR2985179B1 (fr) * 2012-01-02 2020-05-15 L'oreal Composition cosmetique aqueuse solide comprenant de l'alkylcellulose, au moins deux huiles non volatiles et au moins deux agents tensioactifs
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
EP3600320A4 (en) 2017-03-31 2020-12-16 Acura Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR THE SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL SUBSTANCES
IT201800011123A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione cronotropica di sartani
CA3187551A1 (en) * 2020-07-28 2022-02-03 Fang Zhou Novel gastroretentive extended release dosage form

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2140687A (en) * 1938-02-04 1938-12-20 Claude W Mcqueen Tractor drive take-off
NZ206600A (en) 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4693896A (en) 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
IT1188212B (it) 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
DE69229881T2 (de) * 1991-10-04 1999-12-09 Yoshitomi Pharmaceutical Industries, Ltd. Tablette mit verzögerter freisetzung
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
ATE128363T1 (de) 1993-05-15 1995-10-15 Boehringer Mannheim Gmbh Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
US6332819B1 (en) * 1999-10-08 2001-12-25 Jerrold K. Emmons Object retrieval device used in water
US6720005B1 (en) 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
EA005537B1 (ru) 2001-07-10 2005-04-28 Тева Фармасьютикал Индастриес Лтд. Система доставки лекарственного вещества по нулевому порядку, нулевому порядку - двухстадийной, возрастающей или убывающей доставки препарата
ITMI20020514A1 (it) 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
ITMI20020515A1 (it) 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
WO2004108067A2 (en) 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
AP2006003602A0 (en) 2003-09-19 2006-04-30 Sun Pharmaceutical Ind Ltd Oral drug delivery system

Similar Documents

Publication Publication Date Title
JP2007505894A5 (enExample)
FI113941B (fi) Menetelmä pH-herkällä laukaisimella varustettujen, osmoottisten, hajoavien välineiden valmistamiseksi aineen vapauttamiseksi
US8470367B2 (en) Oral drug delivery system
WO2004108067A3 (en) Programmed drug delivery system
JPH0269414A (ja) 持続的制御放出パターンを有する生物活性物質コーティング剤
RU2006143540A (ru) Содержащие варденафил лекарственные формы с регулируемым высвобождением действующего вещества
JP2011512349A (ja) 経口放出制御錠剤
KR20130067255A (ko) 경구 투여 형태
WO2001043721A2 (en) Dosage forms having a barrier layer to laser ablation
CA3165394A1 (en) Soluble rear layer for oral thin film
CA2601800C (en) Oral drug delivery system
US10226428B2 (en) Oral drug delivery system
KR101048925B1 (ko) 조절 약물 방출을 위한 경구 투여 제형
CA2490412A1 (en) Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
US20130059004A1 (en) Oral drug delivery system
AU2006209212A1 (en) Controlled release compositions comprising an antipsychotic agent
ES2382551T3 (es) Sistema de administración de fármacos orales
AU2004261277A1 (en) Permeation-Resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
MXPA06002994A (en) Oral drug delivery system
MXPA06001197A (en) Osmotic engine and dosage form for controlled release of a liquid active agent formulation